Edwards Lifesciences CorpEW

Market cap

$53.6B

P/E ratio

38.2x

	Dec 31, 2010	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Net sales	1,447	1,679	1,900	2,046	2,323	2,494	2,964	3,435	3,723	4,348	4,386	5,233	5,382	6,005
Cost of sales	408	490	495	522	626	617	797	875	939	1,114	1,081	1,249	1,080	1,380
Gross profit	1,039	1,189	1,405	1,523	1,697	1,877	2,166	2,560	2,783	3,234	3,306	3,984	4,302	4,625
Selling, General and Administrative Expense	550	642	705	746	858	851	905	985	1,089	1,242	1,228	1,494	1,568	1,825
Research and Development Expense	204	246	291	323	347	383	443	553	622	753	761	903	945	1,072
Litigation, Settlements And Legal Costs	-	-	-	-	-	-	-	-	-	-	-	-	-	204
Change in fair value of contingent consideration liabilities (Note 12)	-	-	-	-	-	-	-	-10	-6	-6	14	-124	-36	-26
Other Nonrecurring (Income) Expense	23	22	16	-67	71	-	35	60	116	65	-	-	61	17
Operating income	-	-	-	-	-	-	-	-	748	1,147	898	1,690	1,749	1,534
Interest expense	2	3	4	10	17	17	19	23	30	21	16	18	19	18
Interest income	1	3	5	5	6	8	11	20	32	32	23	17	36	67
Other income, net (Note 17)	-	-	-	-	-	-	-5	-8	4	8	12	13	3	14
Income before provision for income taxes	268	284	391	515	1,144	622	738	1,035	761	1,167	917	1,702	1,767	1,598
Income Tax Expense (Benefit)	50	47	98	124	333	128	168	451	39	120	93	199	246	199
Net income	218	-	-	-	-	-	-	-	-	-	-	-	-	1,399
Net loss attributable to noncontrolling interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-3
Net income attributable to Edwards Lifesciences Corporation.	218	-	-	-	-	-	-	-	-	-	-	-	-	1,402
Earnings Per Share, Basic	1.92	2.07	2.55	3.51	7.62	2.3	2.67	2.77	3.45	5.03	1.32	2.41	2.46	2.31
Earnings Per Share, Diluted	1.83	1.98	2.48	3.44	7.48	2.25	2.61	2.7	3.38	4.93	1.3	2.38	2.44	2.3